Houston Medical Times
Oncology Research Immunotherapy: Fighting Cancer from Within By Henna M. Malik, M.D., to attack cancer cells to stop or slow Texas Oncology their growth or limit the cancer’s
M
odern In the fight against cancer, chemotherapy and radiation have been the primary “go-to” treatment options for decades, and a significant amount of research has focused on making these more effective. Immunotherapy now is making its way to the forefront of cancer care thanks to advancements in medical technology and research – even though breakthrough experiments in this treatment method date back to the 1890s. Cancer researchers are just starting to scratch the surface of what may be one of the biggest revolutions in cancer treatment in our lifetimes: harnessing the immune system to help fight cancer. Immunotherapy uses certain parts of a person’s immune system
ability to spread. When used alone or in combination with other types of treatments, including chemotherapy, radiation, or surgery, immunotherapy has been shown to improve patient outcomes. Unlocking the Power of the Human Immune System In the late 1800s, New York physician Dr. William Coley discovered that some cancer patients benefited when their immune systems were “enhanced” with certain bacteria. Coley’s treatment concept faded as advances in chemotherapy, radiation therapy, and surgery developed. However, in the last several decades, researchers returned to Coley’s intriguing idea to give the body’s immune system the boost it needs to fight cancer. Vaccines, which are patient and cancer specific, have been developed for some forms of cancer. They may boost an immune system response or help prevent a future recurrence.
Celebrating
Page 5
S o m e immunotherapy is not specific to a cancer type. Interleukins and interferons help the immune system resist cancer and viral infections, which has proven effective for some forms of cancer. Other types of immunotherapy are more specific. Your body already makes antibodies to fight infections like the flu. Scientists are now designing antibodies to target specific antigens in cancer cells while not affecting healthy cells. The Role of Clinical Trials New breakthroughs, like immunotherapy, are successful only if there are patients who are willing to participate in the research. While immunotherapy is not currently available for all forms of cancer, the treatments that have been fully approved or are in clinical trials are radically changing cancer treatment – for the better. Clinical trials that included Texas patients and physicians were
instrumental in the development of a form of immunotherapy called CAR-T, or Chimeric Antigen Receptor T cell therapy. This personalized therapy involves engineering a patient’s own immune system’s blood cells – arming the cells, so to speak – to attack cancer cells. During the complex procedure, doctors remove some of the patient’s T cells, a type of white blood cell, which are then genetically reprogrammed to identify and attack cancer. Weeks later, doctors then infuse the re-engineered cells back into the patient’s body. Looking Toward the Horizon The Food and Drug Administration first approved the new see Oncology Research...page 10
Over 30 Years in Texas!
98% Customer Recommended n Nationally Recognized Energy Program Flexible Floor Plans n 10 Year Structural Warranty Smart Home Technology
Build On Your Lot Program
New homes from the $190s – $1 Million+
Built Around You
Prices and availability subject to change without notice.
medicaltimesnews.com
February 2021
